Highlights Danube AG

Equities

DSFIR

CH1216478797

End-of-day quote Euronext Amsterdam Other stock markets 06:00:00 2024-06-10 pm EDT			5-day change	1st Jan Change
98.2 ^CHF	-0.08%		-2.96%	+6.74%

09:59am	Dsm-firmenich to Sell Yeast Extract Business to France's Lesaffre	MT
12:00am	Lesaffre et Compagnie, SA agreed to acquire Yeast Extract Business of DSM-Firmenich.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dsm-firmenich to Sell Yeast Extract Business to France's Lesaffre	03:59am	MT
Lesaffre et Compagnie, SA agreed to acquire Yeast Extract Business of DSM-Firmenich.	2024-06-11	CI
Dsm-firmenich sees boost as weight-loss drugs spur healthier choices	Jun. 10	RE
Global markets live: GSK, Walt Disney, Blackstone, Boeing, Microsoft...	Jun. 03
Dsm-firmenich to De-prioritize Certain Business Activities Under New Strategy	Jun. 03	MT
DSM-Firmenich sees mid-term adjusted EBITDA margin of 22-23%	Jun. 03	RE
Dsm-firmenich to Build Centralized Financing Structure Under Cross Guarantee Deal	May. 31	MT
Elanco Says FDA Confirms Bovaer Meets Safety, Efficacy Requirements	May. 28	MT
Dsm-Firmenich Ag Approves the Dividend, Payable May 16, 2024	May. 07	CI
Tranche Update on DSM-Firmenich AG's Equity Buyback Plan announced on April 8, 2024.	May. 07	CI
DSM-Firmenich AG's Equity Buyback announced on April 8, 2024, has closed with 1,500,000 shares, representing 0.57% for ?156.59 million.	May. 02	CI
Global markets live: Etsy, Qualcomm, Carvana, Rio Tinto, Apple...	May. 02
DSM-FIRMENICH : Vitamin trouble is going to fade	May. 02
DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital.	Apr. 08	CI
DSM-Firmenich AG authorizes a Buyback Plan.	Apr. 07	CI
DSM-FIRMENICH : A stronger long-term outlook	Apr. 05
Quiz sales fall, names new CEO; Byotrol eyes AIM exit	Apr. 03	AN
Quotes from Dutch companies on the worsening business climate	Mar. 12	RE
ASML's threat to leave uncovers deeper concerns in Netherlands Inc.	Mar. 12	RE
Jingjiang Cosfocus Health Technology Co., Ltd. acquired DSM Jiangshan Pharmaceutical Co., Ltd from DSM-Firmenich AG.	Mar. 07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

DSM-FIRMENICH : Vitamin trouble is going to fade

May 02, 2024 at 11:26 am EDT